Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lavender + dodder
- Development stage
- Unknown
- Lead developer
- Tehran University of Medical Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lavender + dodder is a combination herbal formulation consisting of extracts from *Lavandula* (lavender) and *Cuscuta* (dodder), traditionally used in Persian medicine. This combination has been studied as a syrup for the treatment of major depressive disorder (MDD) with anxious distress. In clinical trials, the herbal syrup demonstrated efficacy comparable to citalopram in reducing depression scores over six weeks, with a significantly greater reduction in anxiety symptoms at week six compared to citalopram. The mechanism of action is not fully elucidated but is presumed to involve modulation of neurotransmitter systems and anxiolytic/antidepressant effects attributed to both plant components[1][3][4]. The product is considered effective and well-tolerated as an adjunct or alternative therapy for MDD with anxious distress.
- Other names
- lavender-dodder syruplavender and dodder combined herbal syrup
02
Targets
SERT (Sodium-dependent serotonin transporter)NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on lavender + dodder.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lavender + dodder.